Clinical Trial Update: Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether combining ranibizumab with photodynamic therapy improves outcomes in wet age-related macular degeneration; current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Macular Degeneration, Visual Acuity | Phase 4 | Status: UNKNOWN